Nalaganje...
Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response ((,)✰✰)
Human cytomegalovirus (HCMV) is a major cause of disability in congenitally infected infants and in the immunosuppressed. There is currently no licensed prophylactic HCMV vaccine. The HCMV envelope glycoprotein B (gB) is considered a major vaccine target antigen based on its critical role in mediati...
Shranjeno v:
| izdano v: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556890/ https://ncbi.nlm.nih.gov/pubmed/30082162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.07.056 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|